Abbott Laboratories's ticker is and the CUSIP is 028241000. A total of 1 filers reported holding Abbott Laboratories in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,405,225 | +88.8% | 14,509 | +112.5% | 0.30% | +77.2% |
| Q2 2023 | $744,292 | +3.6% | 6,827 | -3.8% | 0.17% | -2.3% |
| Q1 2023 | $718,627 | -13.8% | 7,096 | -6.5% | 0.17% | -15.3% |
| Q4 2022 | $833,600 | +10.4% | 7,593 | -2.8% | 0.20% | -6.5% |
| Q3 2022 | $755,000 | +1.1% | 7,812 | +13.5% | 0.22% | +2.9% |
| Q2 2022 | $747,000 | -6.4% | 6,881 | +2.1% | 0.21% | +7.1% |
| Q1 2022 | $798,000 | -17.2% | 6,742 | -1.6% | 0.20% | -10.9% |
| Q4 2021 | $964,000 | +19.3% | 6,850 | +0.1% | 0.22% | +6.3% |
| Q3 2021 | $808,000 | +4.9% | 6,844 | +3.0% | 0.21% | +1.0% |
| Q2 2021 | $770,000 | -0.8% | 6,647 | +2.6% | 0.20% | -8.1% |
| Q1 2021 | $776,000 | -21.3% | 6,476 | -28.1% | 0.22% | -0.4% |
| Q4 2020 | $986,000 | +42.9% | 9,012 | +42.1% | 0.22% | +19.8% |
| Q3 2020 | $690,000 | +17.5% | 6,342 | -1.3% | 0.19% | +4.5% |
| Q2 2020 | $587,000 | +26.5% | 6,425 | +9.3% | 0.18% | -2.2% |
| Q1 2020 | $464,000 | -7.2% | 5,881 | +2.0% | 0.18% | +7.0% |
| Q4 2019 | $500,000 | +16.8% | 5,763 | +12.5% | 0.17% | +8.2% |
| Q3 2019 | $428,000 | -0.5% | 5,123 | 0.0% | 0.16% | -3.7% |
| Q2 2019 | $430,000 | +1.9% | 5,123 | -3.0% | 0.16% | -1.2% |
| Q1 2019 | $422,000 | -11.3% | 5,283 | -19.9% | 0.17% | -20.6% |
| Q4 2018 | $476,000 | +1.7% | 6,593 | +3.2% | 0.21% | +15.5% |
| Q3 2018 | $468,000 | +18.5% | 6,391 | -1.3% | 0.18% | +5.2% |
| Q2 2018 | $395,000 | -17.4% | 6,478 | -18.8% | 0.17% | -19.2% |
| Q1 2018 | $478,000 | -5.7% | 7,980 | -10.2% | 0.21% | +13.9% |
| Q4 2017 | $507,000 | +32.7% | 8,888 | +24.0% | 0.19% | +20.6% |
| Q3 2017 | $382,000 | -56.5% | 7,167 | -60.3% | 0.16% | -53.2% |
| Q2 2017 | $878,000 | +3.3% | 18,060 | -5.7% | 0.33% | -7.0% |
| Q1 2017 | $850,000 | +33.0% | 19,152 | +15.1% | 0.36% | +24.9% |
| Q4 2016 | $639,000 | -8.3% | 16,645 | +1.0% | 0.28% | -12.6% |
| Q3 2016 | $697,000 | +3.3% | 16,476 | -4.0% | 0.33% | -17.5% |
| Q2 2016 | $675,000 | +0.3% | 17,165 | +6.6% | 0.40% | +12.2% |
| Q1 2016 | $673,000 | -13.2% | 16,105 | -6.7% | 0.35% | -20.7% |
| Q4 2015 | $775,000 | +11.0% | 17,265 | -0.6% | 0.44% | +17.5% |
| Q3 2015 | $698,000 | -17.6% | 17,365 | +0.6% | 0.38% | -12.1% |
| Q2 2015 | $847,000 | – | 17,265 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ironwood Investment Counsel, LLC | 9,012 | $986,000 | 0.22% |